CEFADROXIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cefadroxil, and what generic alternatives are available?
Cefadroxil is a drug marketed by Aurobindo Pharma, Chartwell Rx, Cspc Ouyi, Hikma, Ivax Sub Teva Pharms, Lupin, Purepac Pharm, Ranbaxy Labs Ltd, Sandoz, Teva, Teva Pharms, Ani Pharms, Apothecon, Aurobindo, Hikma Pharms, Sun Pharm Inds Ltd, and Ranbaxy. and is included in twenty-three NDAs.
The generic ingredient in CEFADROXIL is cefadroxil/cefadroxil hemihydrate. Nineteen suppliers are listed for this compound. Additional details are available on the cefadroxil/cefadroxil hemihydrate profile page.
Summary for CEFADROXIL
US Patents: | 0 |
Applicants: | 17 |
NDAs: | 23 |
Finished Product Suppliers / Packagers: | 19 |
Raw Ingredient (Bulk) Api Vendors: | 69 |
Clinical Trials: | 11 |
Patent Applications: | 6,246 |
Drug Prices: | Drug price information for CEFADROXIL |
DailyMed Link: | CEFADROXIL at DailyMed |
Recent Clinical Trials for CEFADROXIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Rothman Institute Orthopaedics | Phase 3 |
University of Colorado, Denver | Phase 1 |
National University Hospital, Singapore | Phase 2 |
Pharmacology for CEFADROXIL
Drug Class | Cephalosporin Antibacterial |